Loading
Cases by country, the UK and NHS pathway and other country lenses, and the expert centres with trials on record.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Shanghai · hospital | China | none recorded | 0 | 2,872 | 31,534 | - | |
Rotterdam · cancer center | Netherlands | none recorded | 0 | 852 | 12,180 | - | |
| Switzerland | none recorded | 0 | 470 | 4,598 | - | ||
Munich · university | Germany | none recorded | 0 | 438 | 4,021 | - | |
Chandigarh · hospital | India | none recorded | 0 | 398 | 3,509 | - | |
São Paulo · cancer center | Brazil | none recorded | 0 | 354 | 2,437 | - | |
Uppsala · hospital | Sweden | none recorded | 0 | 211 | 1,236 | - | |
Madrid · research institute | Spain | none recorded | 0 | 201 | 3,539 | - | |
Rehovot · research institute | Israel | none recorded | 0 | 183 | 3,727 | - | |
Brno · cancer center | Czechia | none recorded | 0 | 155 | 1,946 | - | |
Porto Alegre · hospital | Brazil | none recorded | 0 | 131 | 1,978 | - | |
Calgary, AB · cancer center | Canada | none recorded | 0 | 122 | 1,735 | - | |
Bangkok · cancer center | Thailand | none recorded | 0 | 61 | 924 | - | |
Rome · cancer center | Italy | none recorded | 0 | 37 | 332 | - | |
Cambridge, MA · research institute | United States | 0 | 22 | 500 | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Grade 3 well-differentiated neuroendocrine tumour but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.